Skip to content

Oral iron supplemntation for anemia in ulcerative colitis

Randomized comparison of daily versus alternate day oral iron therapy in patients with ulcerative colitis with Iron deficiency anemia.

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/02/049438
Enrollment
54
Registered
2023-02-03
Start date
Unknown
Completion date
Unknown
Last updated
2023-03-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K51- Ulcerative colitis

Interventions

Intervention1: Alternate Day Oral Ferrous fumarate: 132 mg Ferrous fumarate per oral every other day as a single daily per oral 30 minutes after breakfast Control Intervention1: Daily Oral Ferrous fum

Sponsors

Postgraduate Institute of Medical Education and Research
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: - Ulcerative colitis in remission as defined by Mayo score - Iron deficiency Anemia with Hemoglobin between 8 gram/dL to 12 gram/dL

Exclusion criteria

Exclusion criteria: - Severe anemia (Hemoglobin less than 8 gram/dL) - Patients with active disease of ulcerative colitis - Patients with history of blood transfusion and iron therapy within last 12 weeks -Patients who deny consent or do not agree for follow up -Pregnant or lactating women -Age 100 years -Crohnâ??s disease -Additional causes of anemia like celiac disease, thalassemia and other hemoglobinopathies. -Comorbidities like coronary artery disease, CKD or CLD requiring immediate correction of anemia - Previous intolerance to oral iron therapy

Design outcomes

Primary

MeasureTime frame
Mean Increase in the Hemoglobin levelsTimepoint: 8 weeks

Secondary

MeasureTime frame
Change in serum ferritinTimepoint: 8 weeks;Change in transferrin saturation levelsTimepoint: 8 weeks;Drug adherenceTimepoint: 8 weeks;Frequency of gastrointestinal side effectsTimepoint: 8 weeks

Countries

India

Contacts

Public ContactUday Kiran Mangipudi

PGIMER

docvishalsharma@gmail.com7087008099

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026